Chest pain drug falls short in preventing first episode of ventricular arrhythmia or death
A clinical trial of more than 1,000 patients with implantable cardioverter defibrillators (ICDs) found that the drug ranolazine (commonly used to treat chest pain; brand name Ranexa) was safe but didn't significantly decrease ...
Aug 28, 2018
0
5